We are live on ! Find out more
ALXN

Alexion Pharmaceuticals
ALXN

Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

406 hedge funds and large institutions have $17.3B invested in Alexion Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 406 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $149M | Put options by funds: $97.1M

Holders
406
Holders Change
+406
Holders Change %
–
% of All Funds
13.25%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.2%
New
406
Increased
–
Reduced
–
Closed
–
Calls
$149M
Puts
$97.1M
Net Calls
+$51.9M
Net Calls Change
+$51.9M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PA
126
Profund Advisors
Maryland
$9.34M +$9.76M +101,244 New
TPSF
127
Texas Permanent School Fund
Texas
$9.24M +$9.65M +100,134 New
DekaBank Deutsche Girozentrale
128
DekaBank Deutsche Girozentrale
Germany
$9.08M +$9.4M +97,504 New
VCM
129
Vision Capital Management
Oregon
$8.92M +$9.32M +96,700 New
ProShare Advisors
130
ProShare Advisors
Maryland
$8.71M +$9.09M +94,372 New
IRF
131
IBM Retirement Fund
New York
$8.54M +$8.92M +92,577 New
SCA
132
SAC Capital Advisors
Connecticut
$8.25M +$8.62M +89,400 New
AIG
133
American International Group
New York
$8.18M +$8.55M +88,688 New
WC
134
Wexford Capital
Florida
$8.01M +$8.36M +86,800 New
DL
135
Delta Lloyd
Netherlands
$7.96M +$8.31M +86,240 New
Comerica Bank
136
Comerica Bank
Texas
$7.94M +$8.29M +86,039 New
KI
137
Kalmar Investments
Delaware
$7.63M +$7.97M +82,715 New
O
138
OppenheimerFunds
New York
$7.41M +$7.74M +80,300 New
KBC Group
139
KBC Group
Belgium
$7.39M +$7.72M +80,098 New
ACI
140
AMP Capital Investors
Australia
$7.38M +$7.58M +78,634 New
SOMRS
141
State of Michigan Retirement System
Michigan
$7.31M +$7.64M +79,274 New
TA
142
Teton Advisors
New York
$7.22M +$7.54M +78,260 New
ILIM
143
Irish Life Investment Managers
Ireland
$6.98M +$7.3M +75,717 New
GE
144
General Electric
Ohio
$6.51M +$6.8M +70,614 New
GH
145
GAM Holding
Switzerland
$6.48M +$6.77M +70,250 New
Grantham, Mayo, Van Otterloo & Co (GMO)
146
Grantham, Mayo, Van Otterloo & Co (GMO)
Massachusetts
$6.43M +$6.72M +69,727 New
Public Sector Pension Investment Board (PSP Investments)
147
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$6.17M +$6.45M +66,900 New
TSU
148
TD Securities (USA)
New York
$6.14M +$6.41M +66,540 New
CC
149
Curian Capital
Colorado
$6.13M +$6.4M +66,424 New
CII
150
CR Intrinsic Investors
Connecticut
$6.09M +$6.36M +66,001 New
4 5
6
7 8

ALXN Hedge Fund Activity: Q2 2013 in Review

406 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alexion Pharmaceuticals (ALXN) for Q2 2013, worth a combined $17.3B.

Buyers outnumbered sellers: 406 funds opened new ALXN positions and 0 closed out — a net gain of 406 holders — while 0 added to existing stakes and 0 trimmed.

  • 406 institutional investors held Alexion Pharmaceuticals (ALXN) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $17.3B of Alexion Pharmaceuticals stock for Q2 2013.
  • 406 funds opened new Alexion Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +406 holders.

Based on aggregated 13F filings for Q2 2013.